Skip to main content

CKDXF · Opthea Ltd

Track CKDXF — free
$0.01 At close · Oct 20
Market Cap
$14.64M
Shares
1.37B
Volume · Oct 20 5455 Avg daily vol (1 sessions) 5455

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.01 Open$0.01 Day$0.01–0.01 Available close range$0.01–0.01 Avg vol available · 13d12K Short int2.9M · 0.2% float Short vol100% DataMar 2020–Oct 2026

The closing range uses available history since Jun 8, 2026; less than a full year is stored.

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
0.2%
Latest settlement
View all 122 metrics

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Limited Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 19 · elevated Equity put/call 0.69
Technical
price trend
Buy
50 / 200-day cross No cross
52-week position 100%
near high
Momentum
relative strength
Limited
Not enough data for a confident read.
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.21% of float · ▼ -6.1% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Squeeze score 24
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 830%
annualized · 1-yr
Max drawdown −99%
past year

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Buy
0 · 1 · 1
50 / 200-day cross
No cross Neutral
52-week position
100% Bullish
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Flat
No 13F holder data
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.21% of float · ▼ -6.1% MoM · 1000.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
No 13F holder history
Price context
position in its available closing range
Range low $0 Now $0 · 100% Range high $0

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CKDXF
Opthea Ltd
this stock
$14.64M — — — 0.2%
VRTX
Vertex Pharmaceuticals Inc
$133.55B +18.0% +46.2% 30.7 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
$84.33B +6.1% +20.8% 20.3 2.1%
MRNA
Moderna, Inc.
$80.90B +587.1% +4.3% — 7.7%
CSLLY
Csl Ltd
$65.88B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Short & Settlement
Short Interest Falling
Shares short
2.9M
Days to cover
1000.0d
Change
-187.9K sh
View
Short Volume
Short vol %
100%
As of
Oct 20, 2026
Short Total
View
Off-Exchange
Off-exchange %
100.0%
Week of
Jun 8, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Nov 20, 2025
This year
0
View

Performance

5D 20D 120D MTD YTD
CKDXF -97.5% — — +7.0% -97.6%
SPY -1.2% -0.6% +8.1% +0.8% +12.8%
vs SPY -96.3% — — +6.2% -110.4%